That study included just over 700 women and showed hormones reduced hot flashes and improved moods and sexual health without raising blood pressure or harming arteries – but it also was too small to show any disease differences, such as differing cancer or heart attack rates, Manson says. Manson was a researcher in the WHI and in the study presented last week. "We cannot make definite statements, but everything was headed in the right direction," says Schierbeck, a researcher at Hvidovre Hospital, Kettegård.īut the numbers "are just far too small" to say much of anything about disease risk, says JoAnn Manson, chief of preventive medicine at Brigham and Women's Hospital, Boston. No statistically significant differences in breast cancers or cancers combined or in strokes and blood clots, though, again, actual numbers were small: For instance there were just 11 strokes in treated women and 14 in untreated women. seven) were too small to create meaningful statistics on their own.
That difference was statistically significant. Sixteen deaths, heart attacks and cases of heart failure combined in the users, vs. During the therapy years, the researchers found: The sharp drop in use "is a shame, because hormone therapy seems to have a very positive impact on quality of life," for many women, says Louise Lind Schierbeck, lead researcher on the new study, which followed women for 16 years, including 10 years of therapy.
0 kommentar(er)
